Finder makes money from featured partners, but editorial opinions are our own.

How to buy TC BioPharm stock in Canada

Own TC BioPharm shares in just a few minutes.

TC BioPharm Holdings PLC is a biotechnology business based in the US. TC BioPharm shares (TCBP.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $0.43 – a decrease of 5.8% over the previous day. TC BioPharm employs 60 staff and has a market cap (total outstanding shares value) of $4.1 million.

How to buy shares in TC BioPharm

  1. Choose a platform. If you're a beginner, our stock-dealing table below can help you choose.
  2. Open your account. Provide your personal information and sign up.
  3. Confirm your payment details. You'll need to fund your account with a bank transfer, debit card or credit card.
  4. Search the platform for stock code: TCBP in this case.
  5. Research stocks. The platform should provide the latest information available.
  6. Buy your stocks. It's that simple.
The whole process can take as little as 15 minutes. You'll need a smartphone or computer, an internet connection, your passport or driving licence and a means of payment.

Best for Beginners

CIBC Investor's Edge


  • Easy to use platform
  • Low fees
  • Student and young investor discounts

Best for Lowest Commissions

Finder Award

Interactive Brokers


  • Access to international stock exchanges
  • Low margin rates
  • Powerful research tools

Best for Easy-to-use App

Questrade


  • $50 in free trades
  • Low commissions
  • Easy-to-use app

Is it a good time to buy TC BioPharm stock?

Only you can make the decision on the time to leap. The gauge below shows real-time ratings that are based on 26 popular indicators such as moving averages, for specific time periods. It's not a recommendation but is simply technical analysis that can form part of your research.

Finder might not agree with the analysis and we take no responsibility. We also give no representations or warranty on the accuracy or completeness of the information provided on this page.

Buy TC BioPharm stocks from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Note: The dollar amounts in the table below are in Canadian dollars.

1 - 4 of 4
Name Product Finder Rating Available Asset Types Stock Trading Fee Account Fee Signup Offer Table description
Interactive Brokers
Finder Rating:
★★★★★
4.3 / 5
Stocks, Bonds, Options, ETFs, Currencies, Futures
min $1.00, max 0.5%
$0
N/A
Winner for Best Overall Broker in the Finder Stock Trading Platform Awards.
CIBC Investor's Edge
Finder Rating:
★★★★★
3.8 / 5
Stocks, Bonds, Options, Mutual Funds, ETFs
$4.95–$6.95
$0 if conditions met, or $100
N/A
An easy-to-use platform with access to a variety of tools to help you trade with confidence.
Questrade
Finder Rating:
★★★★★
4.3 / 5
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs, International Equities, Precious Metals
$4.95 - $9.95
$0
Get $50 in free trades when you fund your account with a minimum of $1,000.
Opt for self-directed investing and save on fees or get a pre-built portfolio to take out some of the guesswork.
CASHBACK
Qtrade Direct Investing
Finder Rating:
★★★★★
3.7 / 5
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs
$6.95 - $8.75
$0 if conditions met, otherwise $25/quarter
Get up to $150 cashback. Use promo code OFFER150. Conditions apply. Ends October 31, 2023.
Low trading commissions and an easy-to-use platform with access to powerful tools and a wide selection of investment options.
loading
[/expander_content] [/expander]

TC BioPharm financials

Revenue TTM $3.8 million
Gross profit TTM $3.8 million
Return on assets TTM -78.54%
Return on equity TTM 0%
Profit margin -36.15%
Book value $-0.03
Market capitalisation $4.1 million

TTM: trailing 12 months

TC BioPharm share dividends

We're not expecting TC BioPharm to pay a dividend over the next 12 months.

Have TC BioPharm's shares ever split?

TC BioPharm's shares were split on a 1:50 basis on 20 November 2022. So if you had owned 50 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your TC BioPharm shares – just the quantity. However, indirectly, the new 4900% higher share price could have impacted the market appetite for TC BioPharm shares which in turn could have impacted TC BioPharm's share price.

TC BioPharm overview

TC Biopharm (Holdings) Plc, a clinical-stage biopharmaceutical company, focuses on developing immunotherapy products based on its allogeneic gamma delta T cell platform. Its product pipeline includes OmnImmune, an allogeneic unmodified gamma-delta T cell therapy product used in the treatment of acute myeloid leukemia; and ImmuniStim, an unmodified cell therapy to treat COVID-19. The company was founded in 2013 and is headquartered in Motherwell, the United Kingdom. .

Frequently asked questions


Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.

More on investing

How do ETFs work?

How do ETFs work?

Your guide to how ETFs work and whether this type of investment is right for you.

Read more…
How to read stock charts

How to read stock charts

Learning how to read stock charts and recognize chart patterns can unlock your success as a trader.

Read more…
What are stocks?

What are stocks?

Owning a stock means you own part of a company and can potentially grow your wealth. But there is a risk of loss.

Read more…

More guides on Finder

Ask an Expert

You must be logged in to post a comment.

Go to site